| Mepha Pharma AG - Bosentan-Mepha 125 mg, Filmtabletten | | 65991 | | 02 | | Bosentan-Mepha 125 mg | | Filmtabletten | | C02KX01 | | Bosentan | | 21.03.2017 | | |
| | Composition | | bosentanum 125 mg ut bosentanum monohydricum 129.082 mg, maydis amylum, amylum pregelificatum, carboxymethylamylum natricum A 7.5 mg, povidonum, glyceroli dibehenas, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, E 171, E 172 (flavum), E 172 (rubrum), ethylcellulosum, natrii laurilsulfas, alcohol cetylicus, pro compresso obducto, natrium 0.316 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Bosentan | 125 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Bosentan | 125 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Alcohol Cetylicus | | | | Amylum Pregelificatum | | | | Carboxymethylamylum Natricum A | 7.5 mg | | | E 171 | | color. | | E 172 | | color. | | Ethylcellulosum | | | | Glyceroli Dibehenas | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Maydis Amylum | | | | Natrii Laurilsulfas | | | | Sodium | 0.316 mg | | | Povidone | | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
| |
| |
|
